The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. / AM, Buckle; R, Mottram; A, Pierce et al.
Yn: Molecular Medicine, Cyfrol 6, 01.10.2000, t. 892-902.
Yn: Molecular Medicine, Cyfrol 6, 01.10.2000, t. 892-902.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
AM, B, R, M, A, P, GS, L, N, R, JA, M & AD, W 2000, 'The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells', Molecular Medicine, cyfrol. 6, tt. 892-902. https://doi.org/10.1007/BF03401826
APA
AM, B., R, M., A, P., GS, L., N, R., JA, M., & AD, W. (2000). The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. Molecular Medicine, 6, 892-902. https://doi.org/10.1007/BF03401826
CBE
AM B, R M, A P, GS L, N R, JA M, AD W. 2000. The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. Molecular Medicine. 6:892-902. https://doi.org/10.1007/BF03401826
MLA
AM, Buckle et al. "The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells". Molecular Medicine. 2000, 6. 892-902. https://doi.org/10.1007/BF03401826
VancouverVancouver
AM B, R M, A P, GS L, N R, JA M et al. The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. Molecular Medicine. 2000 Hyd 1;6:892-902. doi: 10.1007/BF03401826
Author
RIS
TY - JOUR
T1 - The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells
AU - AM, Buckle
AU - R, Mottram
AU - A, Pierce
AU - GS, Lucas
AU - N, Russell
AU - JA, Miyan
AU - AD, Whetton
PY - 2000/10/1
Y1 - 2000/10/1
U2 - 10.1007/BF03401826
DO - 10.1007/BF03401826
M3 - Article
VL - 6
SP - 892
EP - 902
JO - Molecular Medicine
JF - Molecular Medicine
SN - 1528-3658
ER -